Diabetic retinopathy (DR) is a common cause of blindness. Although many studies have indicated an association between homocysteine and DR, the results so far have been equivocal. Amongst the many determinants of homocysteine, B-vitamin status was shown to be a major confounding factor, yet very little is known about its relationship to DR. In the present study, we, therefore, investigated the status of B-vitamins and homocysteine in DR. A cross-sectional case–control study was conducted with 100 normal control (CN) subjects and 300 subjects with type-2 diabetes (T2D). Of the 300 subjects with T2D, 200 had retinopathy (DR) and 100 did not (DNR). After a complete ophthalmic examination including fundus fluorescein angiography, the clinical profile and the blood levels of all B-vitamins and homocysteine were analyzed. While mean plasma homocysteine levels were found to be higher in T2D patients compared with CN subjects, homocysteine levels were particularly high in the DR group. There were no group differences in the blood levels of vitamins B1 and B2. Although the plasma vitamin-B6 and folic acid levels were significantly lower in the DNR and DR groups compared with the CN group, there were no significant differences between the diabetes groups. Interestingly, plasma vitamin-B12 levels were found to be significantly lower in the diabetes groups compared with the CN group; further, the levels were significantly lower in the DR group compared with the DNR group. Higher homocysteine levels were significantly associated with lower vitamin-B12 and folic acid but not with other B-vitamins. Additionally, hyperhomocysteinemia and vitamin-B12 deficiency did not seem to be related to subjects' age, body mass index, or duration of diabetes. These results thus suggest a possible association between vitamin-B12 deficiency and hyperhomocysteinemia in DR. Further, the data indicate that vitamin-B12 deficiency could be an independent risk factor for DR.
Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844–851.
Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, et al. (2004) Eye Diseases Prevalence Research Group: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552–563.
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329: 977–986.
Turner R (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853.
Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, et al. (2005) Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study. Invest Ophthalmol Vis Sci 46: 2328–33.
Rema M, Ponnaiya M, Mohan M (1996) Prevalence of retinopathy in non-insulin dependent diabetes mellitus at a diabetes center in southern India. Diab Res Clin Pract 34: 29–36.
Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN (1999) Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol 83: 937–40.
Nirmalan PK, Katz J, Robin AL, Tielsch JM, Namperumalsamy P, et al. (2004) Prevalence of vitreoretinal disorders in a rural population of Southern India: the Aravind Comprehensive Eye Study. Arch Ophthalmol 122: 581–586.
Keenan HA, Costacou T, Sun JK, Doria A, Cavellerano J, et al. (2007) Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care 30: 1995–1997.
Fu YP, Hallman DM, Gonzalez VH, Klein BE, Klein R, et al. (2010) Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol, 2010 pii: 861291.
Rema M, Saravanan G, Deepa R, Mohan V (2002) Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diab Med 19: 910–916.
Martini LA, Catania AS, Ferreira SR (2010) Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev 68: 341–54.
Thornalley PJ, Babaei-Jadidi R, Ali AH (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50: 2164–2170.
Coral K, Angayarkanni N, Gomathy N, Bharathselvi M, Pukhraj R, et al. (2009) Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase. Invest Ophthalmol Vis Sci 50: 3607–12.
Hoogeveen EK, Kostense PJ, Eysink PE, Polak BC, Beks PJ, et al. (2000) Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn Study. Arch Intern Med 160: 2984–2990.
Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, et al. (2003) DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41: 1392–403.
Misra A, Vikram NK, Pandey RM, Dwivedi M, Ahmad FU, et al. (2002) Hyperhomocysteinemia and low intakes of folic acid and vitamin B 12 in urban North India. Eur J Nutr 41: 68–77.
Goldstein M, Leibovitch I, Yeffimov I, Gavendo S, Sela BA, et al. (2004) Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy. Eye 18: 460–465.
Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Narayan KM, et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes. Diabetologia 46: 766–772.
Selhub J, Jacques PF, Wilson PWF, Rash D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270: 2693–2698.
Vermeulen EGJ, Stehouwer CDA, Twisk JDR, Van den Berg M, de Jong SC, et al. (2000) Effect of homocysteine lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomized, placebo-controlled trial. Lancet 355: 517–522.
Chiu CJ, Milton RC, Gensler G, Taylor A (2007) Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am J Clin Nutr 86: 180–188.
Giovanni JPS, Chew EY, Clemons TE (2007) Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-relatedmacular degeneration in a case-control study: AREDS report No. 20. Arch Ophthalmol 125: 671–679.
Giovanni JPS, Chew EY, Clemons TE (2007) Age-Related Eye Disease StudyResearch Group. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22. Arch Ophthalmol 125: 1225–1232.
Hammes HP, Du X, Edelstein D (2003) Benfotiamine blocks three major path-ways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9: 294–299.
Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, et al. (1998) The San Luis Valley Study: Antioxidant nutrient intake and diabetic retinopathy. Ophthalmol 105: 2264–2270.
Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, et al. (2008) Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 51: 29–38.
Early Treatment of Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic colour fundus photographs - an extension of the modified Airlie House Classification. ETDRS Report 10. Ophthalmol 98: 786–806.
Reddy GB, Satyanarayana A, Balakrishna N, Ayyagari R, Padma M, et al. (2008) Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy. Mol Vis 14: 593–601.
Pitla S, Nagalla B (2009) Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians. Ann Nutr Metab 54: 1–6.
Ubbink JB, Hayward Vermaak WJ, Bissbort S (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565: 441–446.
